Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Asia Pacific Markets Poised to Witness Rapid Growth and Activity in Clinical Trials in the Near Future - New analysis from Frost & Sullivan, Competing in the APAC CRO: What Pharma and Biotech Companies want and how to compete for their Business, finds that the Asian CRO markets (Phase I–IV) earned revenues of $1.2 billion in 2006 and estimates this to reach
Asia Pacific Markets Poised to Witness Rapid Growth and Activity in Clinical Trials in the Near Future

 

PRZOOM - /newswire/ - Singapore, Singapore, 2007/10/01 - New analysis from Frost & Sullivan, Competing in the APAC CRO: What Pharma and Biotech Companies want and how to compete for their Business, finds that the Asian CRO markets (Phase I–IV) earned revenues of $1.2 billion in 2006 and estimates this to reach.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Asia Pacific countries are steadily becoming the locations of choice for pharmaceutical and biotechnology companies wanting to conduct clinical trials. Lower costs, fresh and large patient pools, and services that meet global standards are some of the key factors that make countries such as India, China, Australia, Hong Kong, and Taiwan viable options to western nations for conducting clinical trials.

New analysis from Frost & Sullivan (pharma&biotech.frost.com), Competing in the APAC CRO: What Pharma and Biotech Companies want and how to compete for their Business, finds that the Asian CRO markets (Phase I–IV) earned revenues of $1.2 billion in 2006 and estimates this to reach $2 billion in 2010.

“In the very near future, countries in Asia will see a growing number of clinical trials conducted and a substantial growth in the contract research outsourcing (CRO) Markets,” notes Frost & Sullivan Research Analyst Sushma Rajan. “While India and China are already much talked about as hotspots for clinical trials, the other countries that will see increased activity are Taiwan, Hong Kong, and to an extent, South Korea."

The high cost of conducting clinical trials and depletion in fresh clinical trial participants are increasingly challenging countries in the west. These two factors are driving the re-location of clinical trials toward Asia, wherein costs of conducting trials are lower, a relatively untouched patient pool is more easily accessible, and CRO services meet global standards.

However, with a growing number of CROs in Asia and increased competition, one of the challenges CROs face is to know the exact client requirements and the criteria used in selecting CRO partners. Other challenges confronting the CRO industry include the recruitment and retention of qualified clinical research associates and regulatory hurdles and bureaucracies.

“In an increasingly competitive market, it becomes imperative for CROs to build enduring customer relationships, based on a sound understanding of customer needs, priorities, and goals,” says Rajan. “Customer satisfaction, thus takes on increased importance, tailored to meet the requirements of dynamic pharmaceutical and biotechnology companies.”

While understanding what pharmaceutical and biotechnology companies want and their CRO selection criteria is critical, delivering value to customer businesses is equally important. This requires CROs to enhance requisite capabilities in terms of a strong base of qualified personnel and services that meet global standards and support trials across all phases of clinical research.

Competing in the APAC CRO: What Pharma and Biotech Companies want and how to compete for their Business is part of the Pharmaceutical & Biotechnology Growth Partnership Service. It provides an understanding of the key motivations for companies to outsource drug development and the benefits that they seek and experience from outsourcing. Also highlighted are the criteria that pharmaceutical and biotechnology companies use to select their CRO partners. Interviews with the press are available.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Competing in the APAC CRO: What Pharma and Biotech Companies want and how to compete for their Business, then send an email to Jasminder Kaur, Corporate Communications, at jkaur[.]frost.com with your full name, company name, title, telephone number, fax number, and email address. Upon receipt of the above information, an overview will be sent to you by email.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Asia Pacific Markets Poised to Witness Rapid Growth and Activity in Clinical Trials in the Near Future

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Jasminder Kaur 
+65.6890.0937 jkaur[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
Next-generation Natural Materials to Replace Traditional Synthetic Materials in Personal Care Products Finds Frost & Sullivan
Digital Innovation-driven Diagnostic Advances Transform Smart Healthcare Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Deb Sheppard - Medium Psychic Author Speaker

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today